Daniel Legault

Mr. Daniel Legault is an Independent Director at NeuPath Health, Inc., a President & Chief Executive Officer at Antibe Holdings, Inc., a Member at New York State Bar Association and a Member at The Law Society of Upper Canada.
He is on the Board of Directors at NeuPath Health, Inc. Mr. Legault was previously employed as a President, Chief Executive Officer & Director by Antibe Therapeutics, Inc., a Principal by Exchange Solutions, Inc., a President by Opal Sky, Inc., a President by Butterfield & Robinson, Inc., and a Chief Operating Officer by Embryome, Inc. He also served on the board at Green Shield Canada, Klinik Health Ventures Corp.
and Save the Children International.
He received his graduate degree from Queen's University.